Biosecurity Act 1993

Importation of risk goods - Import health standards

24: Review

You could also call this:

"Checking if concerns about import health standards were properly considered"

If you were consulted about an import health standard under section 23(3)(b), you can ask the Director-General if they thought about the scientific evidence you were concerned about when they developed the standard. The Director-General has to make sure there is a way to set up a panel to review if the scientific evidence you were concerned about was considered properly. This panel will be independent, meaning they are not part of the group that developed the standard.

The Director-General must have a process that explains how the panel will be set up and how its members will be chosen, including what knowledge and experience they need to have. The process must also say what the panel must do when it reviews the standard and what it must report back to the Director-General. If the panel reports back to the Director-General, the Director-General must think about what the panel says, decide what to do about the issue, and explain why they made that decision. You can be part of this process if you were consulted under section 23(3)(b) and you have concerns about the standard. The Director-General will make sure the panel follows the right procedures when it does its review.

This text is automatically generated. It might be out of date or be missing some parts. Find out more about how we do this.

This page was last updated on

View the original legislation for this page at https://legislation.govt.nz/act/public/1986/0120/latest/link.aspx?id=DLM315286.


Previous

23: From draft to recommendation, or

"How a new import health standard is created and approved"


Next

24A: Issue, or

"When to issue a new biosecurity standard"

Part 3Importation of risk goods
Import health standards

24Review

  1. A person consulted under section 23(3)(b) may raise with the Director-General the question of whether scientific evidence about which the person raised a significant concern received sufficient regard in the development of the standard.

  2. The Director-General must ensure that there is a process to establish an independent review panel to review the question of whether scientific evidence about which a person has raised a significant concern received sufficient regard in the development of the standard.

  3. The process must deal with—

  4. the criteria for setting up the panel; and
    1. how the Director-General will appoint the panel members, including the knowledge and experience that members must have; and
      1. the procedures to be followed by—
        1. a person consulted under section 23(3)(b); and
          1. the panel in undertaking its review; and
          2. the reporting requirements for the panel.
            1. If a panel reports to the Director-General, the Director-General must, as soon as reasonably practicable,—

            2. take the panel's findings and recommendations into account; and
              1. determine the issue in dispute; and
                1. give reasons for the determination.
                  Notes
                  • Section 24: replaced, on , by section 20 of the Biosecurity Law Reform Act 2012 (2012 No 73).